| Goal | 
    To 
      expedite the dissemination of data from research. | 
  
   
    | Objective 
      #1  | 
     
       To provide 
        accurate information concerning current Federally approved treatments 
        for HIV-related conditions.  
     | 
  
   
    |  
       Action 
        Steps 
     | 
     
      Through the use of reference specialists, provide appropriate treatment 
      information to callers, drawing on NLM's database of AHCPR guidelines, in 
      addition to NIH, CDC and other Federal agency guidelines and consensus statements. | 
  
   
    |  
       Description 
     | 
     
      AIDS Treatment Information Service | 
  
   
    |  
       Resources 
     | 
     
       FY95 
     | 
     
       FY96 
     | 
     
       FY97 
     | 
  
   
    |  
       $ 
        75,000 
     | 
     
       $ 
        0 
     | 
     
       $ 
        0 
     | 
  
   
    |  
       Populations 
        Served 
     | 
    HIV-positive 
      individuals, primary care practitioners, case managers, and allied health 
      professionals. | 
  
   
    |  
       Constituency 
        Involvement 
     | 
    HIV-positive 
      individuals and advocacy groups as well as health care professionals. | 
  
   
    | Objective 
      #2  | 
    To 
      provide accurate information to service providers and consumers concerning 
      management of early HIV infection. | 
  
   
    |  
       Action 
        Steps 
     | 
    A 
      panel of experts reviewed relevant literature and summarized findings into 
      specific clinical practice guidelines, which stress the importance of preventing 
      HIV-related opportunistic infections and the link between prevention and 
      early diagnosis. Approximately 2.7 million copies of guideline-related documents 
      have been distributed. | 
  
   
    |  
       Description 
     | 
    Dissemination 
      of AHCPR's HIV-Related Clinical Guidelines. | 
  
   
    |  
       Resources 
     | 
     
       FY95 
     | 
     
       FY96 
     | 
     
       FY97 
     | 
  
   
    |  
       $ 
        60,000 
     | 
     
       $ 
        200,000 
     | 
     
       $ 
        200,000 
     | 
  
   
    |  
       Populations 
        Served 
     | 
    Clinical 
      practitioners, individuals with HIV infection, and those persons caring 
      for persons with HIV. | 
  
   
    |  
       Constituency 
        Involvement 
     | 
    Clinicians, 
      HIV positive persons, and caregivers. | 
  
   
    | Objective 
      #3  | 
    To 
      assess effective and ineffective dissemination strategies employed by community-based 
      HIV education programs. | 
  
   
    |  
       Action 
        Steps 
     | 
    Examined 
      organizational strategies used by several community-based HIV education 
      agencies. Completed in FY 96. | 
  
   
    |  
       Description 
     | 
    Effective 
      Strategies of AIDS Programs in San Francisco. | 
  
   
    |  
       Resources 
     | 
     
       FY95 
     | 
     
       FY96 
     | 
     
       FY97 
     | 
  
   
    |  
       $ 
        60,000 
     | 
     
       $ 
        200,000 
     | 
     
       NA 
     | 
  
   
    | * 
      Part of overall operating budget. | 
  
   
    |  
       Populations 
        Served 
     | 
    Community-based 
      HIV education agencies in San Francisco | 
  
   
    |  
       Constituency 
        Involvement 
     | 
    Advocacy 
      organizations and persons with HIV were included in the research. | 
  
   
    | Objective 
      #4 | 
    Develop 
      Consumer Guide on Use of Zidovudine for the Prevention of Perinatal HIV 
      Infection (076 Guide). | 
  
   
    |  
       Action 
        Steps 
     | 
    Developed 
      guide and related materials which describe the recommendations of the PHS 
      Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of 
      HIV, based on results of AIDS Clinical Trials Group 076. Provided the information 
      in a format and reading level that consumers can comprehend. | 
  
   
    |  
       Description 
     | 
    This 
      guide and related materials will inform pregnant women with HIV about the 
      use of zidovudine (AZT) for the prevention of perinatal HIV infection. | 
  
   
    |  
       Resources 
     | 
     
       FY95 
     | 
     
       FY96 
     | 
     
       FY97 
     | 
  
   
    |  
       $ 
        15,000 
     | 
     
       $ 
        0  
     | 
     
       $ 
        0  
     | 
  
   
    |  
       Populations 
        Served 
     | 
    Pregnant 
      women and women of child-bearing age who have HIV. | 
  
   
    |  
       Constituency 
        Involvement 
     | 
    HIV 
      infected individuals and advocacy groups were involved in the development 
      and review of the guide. The guide is cosponsored by multiple Federal and 
      non-Federal agencies. |